Personal tools
Document Actions

New monitoring method for patients with hepatitis B

A key publication today from Prof. Poynard’s team that combines FibroTest and HBV viral load.

The information is taken from today’s newspapers: Prof. Poynard’s team (Pitie-Salpetriere Hospital, Paris) developed a new method of monitoring for patients with hepatitis B by combining the results of FibroTest with the hepatitis B virus viral load.

The article was published by the prestigious PloS ONE :

plosone-medium.jpg
Read the article
An accurate definition of the status of inactive hepatitis B virus carrier by the combination of non-invasive biomarkers (FibroTest-ActiTest) and viral load. The conventional definition of the inactive hepatitis B virus carrier used the transaminase (ALT) level, liver biopsy, absence of HBe antigen and viral load. The use of FibroTest and ActiTest as biomarkers of fibrosis and hepatic necroinflammatory activity was previously validated as an alternative to hepatic biopsy read more


Excerpt from the article New monitoring method for patients with hepatitis B published in the "Le Monde" newspaper on July 3, 2008: :

le-monde-3-juillet-medium.jpg "How can the progression of hepatitis B be studied in the 300,000 people that are infected in France by the virus that causes this chronic disease? This has been a fundamental public health question ever since antiviral treatments were made available that can effectively prevent progression to cirrhosis or liver cancer. For over a decade this question has fueled lively debates within the specialized medical community."- read more

There is a very significant impact for patients with hepatitis B. According to Prof. Poynard, “With this work, we believe that we have provided proof that it is possible not only to improve but also to simplify the monitoring of progression of the state of health of 300,000 people in France and to a certain extent, that of the four hundred million chronic hepatitis B virus carriers in the world.

To find out more :

Welcome to BioPredictive

Non-invasive liver diagnostic tests.

Learn more

Address

BioPredictive
40 rue du Bac
75007 Paris
FRANCE

Tel : +33 1 45 44 30 64
email : contact@biopredictive.com


 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: